John P. McLaughlin
2011
In 2011, John P. McLaughlin earned a total compensation of $1.2M as President and Chief Executive Officer at PDL BioPharma, a 32% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $368,550 |
|---|---|
| Salary | $585,000 |
| Stock Awards | $201,000 |
| Other | $9,800 |
| Total | $1,164,350 |
McLaughlin received $585K in salary, accounting for 50% of the total pay in 2011.
McLaughlin also received $368.6K in non-equity incentive plan, $201K in stock awards and $9.8K in other compensation.
Rankings
In 2011, John P. McLaughlin's compensation ranked 5,096th out of 10,747 executives tracked by ExecPay. In other words, McLaughlin earned more than 52.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,096 out of 10,747 | 53rd |
Division Manufacturing | 1,840 out of 3,960 | 54th |
Major group Chemicals And Allied Products | 388 out of 1,033 | 62nd |
Industry group Drugs | 241 out of 781 | 69th |
Industry Biological Products, Except Diagnostic Substances | 39 out of 157 | 75th |
Source: SEC filing on April 17, 2014.
McLaughlin's colleagues
We found five more compensation records of executives who worked with John P. McLaughlin at PDL BioPharma in 2011.
2011
Christine Larson
PDL BioPharma
Chief Financial Officer
2011
Christopher Stone
PDL BioPharma
General Counsel
2011
Caroline Krumel
PDL BioPharma
Former Vice President of Finance and Principal Accounting Officer
2011
Danny Hart
PDL BioPharma
General Counsel
2011
Karen Wilson
PDL BioPharma